VRTX vs MRNA: Fair Value Comparison
VRTX's model fair value sits 20.9% below its current price; MRNA's model fair value sits 95.1% below its current price. Of the two, VRTX trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-11-09.
| VRTX | MRNA | |
|---|---|---|
| Price | $550.87 | $269.00 |
| Model fair value (multi-method blend) | $435.72 | $13.09 |
| Model fair value differential | -20.9% | -95.1% |
| Methods with a model value above price | 7 of 8 | 2 of 2 |
| Fundamental strength | B+ | C- |
| Next earnings report | — | — |
More comparisons
VRTX vs REGN · VRTX vs RPRX · MRNA vs REGN · MRNA vs RPRX · All Biotechnology stocks · Compare any two stocks